Institute for Safe Medication Practices
Staff Reporters
A new patient-oriented Web site is scheduled for release this fall to reduce mix-ups over drug names.
The ISMP
The Web site is a partnership of the nonprofit Institute for Safe Medication Practices, and online health service www.iGuard.org, which will send users email alerts about drug-name confusion.
Dug Mix-Ups Not Rare
According to an Associated Press report on September 2nd, nearly 1,500 commonly used drugs have names so similar to at least one other medication that they’ve already caused mix-ups.
Patient Harm
And, according to a major study by the U.S. Pharmacopeia, at least 1.5 million Americans are estimated to be harmed each year from a variety of medication errors, and name mix-ups are blamed for a quarter of them.
The Food and Drug Administration [FDA] – which currently rejects more than a third of proposed names for new drugs because they’re too similar to old ones – is preparing a pilot program that would shift more responsibility to manufacturers to guard against name confusion.
The Site
According to the website, iGuard.org is a healthcare service initiative that helps monitor the safety of medications (including prescription drugs, over-the-counter drugs, nutritional supplements and herbal extracts).
iGuard.org reportedly will help patients stay safer by:
-
Checking the safety of medications, and screening for drug-drug and drug-disease interactions.
-
Alerting members and doctors (optional) as important safety information arises for medications.
-
Provide accessible medication summaries for healthcare teams.
-
Help patients learn and share treatment satisfaction and side effect information within its social community.
Assessment
The goal of the site is to spell-out how to better test for potential mix-ups before companies seek approval to sell their products.
Conclusion
Your thoughts and comments are appreciated.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com or Bio: www.stpub.com/pubs/authors/MARCINKO.htm
Subscribe Now: Did you like this Executive-Post, or find it helpful, interesting and informative? Want to get the latest E-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Copyright 2008 iMBA Inc: All rights reserved, USA, unless otherwise noted. Use is restricted to Executive-Post subscribers only. No redistribution is allowed. To avoid violation of iMBA Inc copyright restrictions and redistribution policy, please register for your own free Executive-Post membership. Detailed information and registration links are available at:
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Referrals: Thank you in advance for your electronic referrals to the Executive-Post
Filed under: Drugs and Pharma, Information Technology, Professional Liability, Quality Initiatives, Research & Development, Risk Management, Uncategorized |














Leave a comment